Robotic Endoscopy Devices Market Size & Growth Forecast 2027–2036, By Segments (Product, End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Robotic Endoscopy Devices Market size was valued at USD 3.2 billion in 2026 and is anticipated to grow at a 8.46% CAGR from 2027 to 2036, surpassing USD 7.21 billion by 2036. The industry revenue for 2027 is calculated at USD 3.43 billion.
Get more details on this report
Request Free Sample ReportRobotic Endoscopy Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America led the market in 2026 due to advanced healthcare facilities, high adoption of minimally invasive procedures, investment in robotic systems, and routine clinical use across specialty care settings.
- Asia Pacific is forecast to grow at a 10.28% CAGR, driven by healthcare infrastructure modernization, expanding access to minimally invasive treatments, and increasing investment in advanced robotic procedural technologies.
Segment Momentum
- Therapeutic devices accounted for 91.39% of the market in 2026, driven by their direct role in minimally invasive treatments where precision, control, and procedural effectiveness are key adoption factors.
- Hospitals are the fastest-growing end-use segment because they concentrate the infrastructure, clinical expertise, and procedural volumes required to integrate robotic endoscopy systems into routine care.
Market Expansion Drivers
- Increasing gastrointestinal disease prevalence accelerating demand for robotic diagnostic and treatment systems.
- Growing adoption of minimally invasive procedures driving robotic endoscopy technology integration.
- Rising hospital investments in AI-assisted surgical platforms strengthening robotic endoscopy deployment.
Leading Market Participants
- Top players in the robotic endoscopy devices market include Intuitive Surgical, Inc. (United States), Medtronic plc (Ireland), Olympus Corporation (Japan), Asensus Surgical, Inc. (United States), CMR Surgical Ltd. (United Kingdom), KARL STORZ SE & Co. KG (Germany), Brainlab AG (Germany), Virtuoso Surgical, Inc. (United States), Johnson & Johnson MedTech (United States), Siemens Healthineers AG (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 3.2 billion
- 2027 Estimated Market Size: USD 3.43 billion.
- Projected Market Size: USD 7.21 billion by 2036
- Growth Forecast: 8.46% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Therapeutic (Product) | Hospitals (End-use) | Laparoscopy (Application)
- Emerging Opportunity Segment: Diagnostic (Product) | Hospitals (End-use) | Colonoscopy (Application)
Market Growth Drivers and Industry Trends
Increasing gastrointestinal disease prevalence accelerating demand for robotic diagnostic and treatment systems
The growing burden of gastrointestinal diseases is increasing the need for diagnostic and therapeutic procedures that can provide precise visualization and controlled intervention. This dynamic will drive the robotic endoscopy devices market as healthcare providers explore robotic systems capable of supporting complex gastrointestinal examinations and treatments. Enhanced procedural control can assist clinicians in navigating challenging anatomical areas and performing interventions with greater precision, strengthening the role of robotic technologies within gastrointestinal care.
Growing adoption of minimally invasive procedures driving robotic endoscopy technology integration
The preference for minimally invasive approaches is encouraging healthcare providers to adopt technologies that can support controlled procedures while reducing the need for more invasive surgical techniques. Consequently, the robotic endoscopy devices market is benefiting from greater integration of robotic systems into minimally invasive gastrointestinal procedures. Robotic assistance can provide improved instrument maneuverability, enhanced procedural control, and greater consistency in complex interventions, making these systems increasingly relevant as hospitals expand minimally invasive treatment capabilities.
Rising hospital investments in AI-assisted surgical platforms strengthening robotic endoscopy deployment
Increasing hospital investment in AI-assisted surgical platforms is creating an enabling environment for the integration of intelligent technologies into endoscopic procedures. The robotic endoscopy devices market will gain momentum as healthcare facilities combine robotic systems with AI-supported capabilities for procedural guidance, visualization, and clinical decision support. These investments can strengthen the technological infrastructure required for advanced endoscopy while helping hospitals pursue more digitally integrated approaches to surgical and diagnostic care.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing gastrointestinal disease prevalence accelerating demand for robotic diagnostic and treatment systems | 2.00% | High | North America, Europe | High | Near Term |
| Growing adoption of minimally invasive procedures driving robotic endoscopy technology integration | 1.80% | High | North America, Asia Pacific | High | Mid Term |
| Rising hospital investments in AI-assisted surgical platforms strengthening robotic endoscopy deployment | 1.50% | Moderate | Asia Pacific, Middle East | Medium | Mid Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America held the largest share of the robotic endoscopy devices market in 2026, reflecting advanced healthcare infrastructure, strong adoption of surgical robotics, and growing interest in minimally invasive procedures. Healthcare providers are increasingly seeking technologies that can improve visualization, procedural precision, and physician control while supporting efficient clinical workflows. Established specialist capabilities, technological readiness, and continued investment in advanced surgical systems reinforce the region’s market leadership.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, driven by expanding hospital infrastructure, increasing adoption of minimally invasive treatments, and rising investment in advanced medical technologies. As healthcare providers modernize surgical capabilities, demand is increasing for robotic systems that can enhance procedural accuracy and support complex endoscopic interventions. Improving access to specialized care and growing clinical acceptance of robotic-assisted procedures are further supporting regional market expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Technology IntegrationGermany adopts robotic endoscopy devices across advanced clinical centers focused on improving procedural accuracy and patient outcomes. German hospitals emphasize technology validation, physician training, and seamless integration with existing endoscopy infrastructure.
France 🇫🇷
Advanced Endoscopy ModernizationFrance modernizes endoscopy services by incorporating robotic technologies into specialized healthcare facilities. French clinicians prioritize enhanced visualization, procedural precision, and efficient treatment pathways while evaluating technologies that complement existing clinical workflows.
Italy 🇮🇹
Surgical Innovation AdoptionItaly increasingly integrates robotic endoscopy devices into tertiary care hospitals seeking enhanced minimally invasive capabilities. Italian healthcare providers focus on clinician expertise, procedural efficiency, and technology adoption that supports complex gastrointestinal interventions.
Japan 🇯🇵
Minimally Invasive AdvancementJapan prioritizes robotic endoscopy technologies that support precise navigation and less invasive gastrointestinal procedures. Japanese healthcare providers focus on improving procedural consistency while incorporating robotics into specialized clinical practice.
South Korea 🇰🇷
Smart Hospital DeploymentSouth Korea expands robotic endoscopy adoption through digitally connected hospitals and advanced medical technology investments. South Korean healthcare providers emphasize integration with imaging systems, clinician efficiency, and improved procedural capabilities across specialized care settings.
United States 🇺🇸
Robotic Procedure AdoptionThe U.S. robotic endoscopy devices market is driven by hospitals seeking greater procedural precision, minimally invasive care, and workflow efficiency. Healthcare providers in the U.S. continue investing in advanced robotic platforms supported by specialist training and clinical integration.
Segment Leadership and Growth Trends
Robotic Endoscopy Devices Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Therapeutic (Largest Segment) vs Diagnostic (Fastest-Growing Segment)
Therapeutic products held the largest share of the robotic endoscopy devices market, accounting for 91.39% in 2026. Robotic endoscopy systems are increasingly used to support complex interventions that require precise instrument control, enhanced visualization, and greater procedural dexterity. The growing adoption of minimally invasive treatment approaches, combined with demand for improved procedural accuracy and surgeon control, is supporting the strong position of therapeutic robotic endoscopy devices. Their expanding role in interventions that previously required more invasive approaches is also contributing to sustained demand.
The diagnostic segment is expected to grow at the fastest pace as healthcare providers increasingly seek advanced visualization and navigation capabilities for earlier and more precise disease identification. Robotic technologies can improve control and access during endoscopic examinations, supporting the evaluation of anatomically challenging areas and enhancing procedural consistency. Greater emphasis on early diagnosis, minimally invasive examination techniques, and technology-enabled clinical decision-making is creating additional opportunities for robotic diagnostic endoscopy.
End-use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)
Hospitals represented the largest share of the robotic endoscopy devices market in 2026 and are also positioned as the fastest-growing end-use segment. Hospitals provide the specialized surgical infrastructure, trained clinical personnel, and multidisciplinary capabilities required to deploy sophisticated robotic endoscopy systems. Increasing investment in advanced minimally invasive procedures, growing procedural volumes, and the integration of robotic technologies into specialized care pathways are supporting adoption. In addition, hospitals' ability to manage complex cases and provide comprehensive perioperative services makes them well suited to the continued expansion of robotic endoscopy.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Diagnostic, Therapeutic | Therapeutic | Diagnostic |
| End-use | Hospitals, Outpatient Facilities | Hospitals | Hospitals |
| Application | Laparoscopy, Bronchoscopy, Colonoscopy, Others | Laparoscopy | Colonoscopy |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Major players in the robotic endoscopy devices market:
1. Intuitive Surgical Inc. (United States)
2. Medtronic plc (Ireland)
3. Olympus Corporation (Japan)
4. Asensus Surgical Inc. (United States)
5. CMR Surgical Ltd. (United Kingdom)
6. KARL STORZ SE & Co. KG (Germany)
7. Brainlab AG (Germany)
8. Virtuoso Surgical Inc. (United States)
9. Johnson & Johnson MedTech (United States)
10. Siemens Healthineers AG (Germany)
The robotic endoscopy devices market is evolving with increasing integration of robotic assistance, AI-guided visualization, and minimally invasive capabilities. Strategic collaborations between technology developers and healthcare institutions are accelerating the introduction of precision-focused surgical systems. Continuous innovation aimed at enhancing procedural control and patient outcomes remains a key competitive driver within the robotic endoscopy segment.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Intuitive Surgical Inc. (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| Olympus Corporation (Japan) | |||||||
| Asensus Surgical Inc. (United States) | |||||||
| CMR Surgical Ltd. (United Kingdom) | |||||||
| KARL STORZ SE & Co. KG (Germany) | |||||||
| Brainlab AG (Germany) | |||||||
| Virtuoso Surgical Inc. (United States) | |||||||
| Johnson & Johnson MedTech (United States) | |||||||
| Siemens Healthineers AG (Germany). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Intuitive Surgical | Mar-24 | Intuitive Surgical received FDA 510(k) clearance for the da Vinci 5, its fifth-generation multi-port robotic surgical system. The platform introduces significant advancements in surgical precision, haptic feedback, and data integration, marking a critical expansion of the company’s flagship robotic portfolio for minimally invasive surgical procedures. |
| Medtronic | Dec-23 | Medtronic entered a definitive agreement to expand its strategic partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals. The deal solidifies Medtronic’s position as the exclusive global distributor of the AI-powered GI Genius endoscopy module and focuses on co-developing an scalable AI ecosystem for future gastrointestinal diagnostic and therapeutic platforms. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Robotic Endoscopy Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Robotic Platform Type | Fixed Robotic Systems, Modular Robotic Systems, Flexible Robotic Systems |
| Degree of Autonomy | Teleoperated Systems, Robot-Assisted Systems, Semi-Autonomous Systems |
| Purchase Model | Capital Equipment Purchase, Leasing, Procedure-Based or Managed-Service Model |
Robotic Endoscopy Devices Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Hospital Capital Investment Readiness Assessment |
|
| Procedure Volume Opportunity Mapping |
|
| Surgeon Adoption and Training Landscape |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the robotic endoscopy devices market?
What are the growth projections for the robotic endoscopy devices industry?
How is the shift toward minimally invasive procedures influencing adoption in the robotic endoscopy devices market?
How are AI-assisted surgical investments shaping deployment of robotic endoscopy systems?
Why are therapeutic robotic endoscopy devices the largest product segment?
Which end-use segment is expanding fastest in the robotic endoscopy devices market?
Why does North America lead the robotic endoscopy devices market?
What factors are accelerating robotic endoscopy devices market growth in Asia Pacific?
Which companies are driving growth in the robotic endoscopy devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization